Late last week, Allergan announced it had sold a group of US patents for its $1.5 billion-a-year ophthalmology blockbuster Restasis (cyclosporine ... such as Mylan and Teva seeking to make ...

JERUSALEM, Dec 17 (Reuters) - (This Dec.17 story has been corrected to say the results were for ulcerative colitis, not for both the diseases, in paragraph 5) Teva and Sanofi said last year they ...

Teva also boasts a compelling growth trajectory, with revenue expected to increase by 15% and EBIT by 30% from 2024 to 2028. Free cash flow yield, currently at 9.8%, is projected to exceed 16% by ...

Sanofi SNY and partner Teva Pharmaceuticals TEVA announced positive data from the phase IIb RELIEVE UCCD study on their investigational anti-TL1A therapy, duvakitug (formerly TEV’574), for the ...

Teva Pharmaceutical (NYSE:TEVA) shares rose for seven straight sessions, as the stock closed about 1% higher at $22.42 on Tuesday. The Israeli drugmaker stock added 34.5% in the preceding six ...

The readout not only exceeded Teva's expectations but also came earlier than expected. Back in July, the partners revealed that the phase 2b trial had completed enrollment early thanks to ...

ADRs of Teva Pharmaceutical (NYSE:TEVA) and Sanofi (NASDAQ:SNY) traded higher in the premarket on Tuesday after the companies said that their experimental antibody therapy, duvakitug, reached the ...

Dec 20 (Reuters) - Teva Pharmaceuticals (TEVA.TA), opens new tab failed to convince a U.S. appeals court on Friday to reverse a decision that would remove patents related to its ProAir HFA inhaler ...

A Teva Pharmaceuticals drug being developed in partnership with Sanofi to hit a promising but competitive target for inflammation now has positive data from a clinical test in the two most common ...

Cyclosporine-drug interactions in adult transplant patients and the impact of age were studied. The medical records of transplant patients receiving cyclosporine therapy were identified. Data on ...

The relief in discomfort lasted up to 9 minutes after instillation. Cold instillation of a cyclosporine A solution reduced instillation discomfort among patients with dry eye disease, with results ...

Teva Pharmaceuticals’TEVA0.63%increase; green up pointing triangle shares soared and Sanofi’sSAN-0.33%decrease; red down pointing triangle stock moved higher following positive results from ...